SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: g.w. barnard who wrote (17841)1/17/1999 3:33:00 PM
From: VLAD  Read Replies (2) | Respond to of 23519
 
gw,

Yes, I read it. Now you will have the 2 researchers from Kentucky along with the 2 researchers from England fighting with Pfizer over patent rights.

Personally, I don't think the nasal spray will fly because of the new danger of an even more precipitous drop of blood pressure in the at risk group.



To: g.w. barnard who wrote (17841)1/17/1999 6:54:00 PM
From: AlienTech  Read Replies (2) | Respond to of 23519
 
>>v, in todays paper, pfe, files for patent for nasal spray application of viagra. <<

AT files patent for finger in nose applicator.

HA! Take that Frostman and your ilk in KY!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News